Latest News
From the Journals
Short course of prednisolone may help distinguish between RA and hand OA
A 3-day course of prednisolone may help clinicians to decide if patients have RA, but the test should not be used in isolation of other surrogate...
From the Journals
Triple therapy found as ‘durable’ as biologic after methotrexate failure
RA patients stay on triple therapy at least as often and with the same results as do those who take a methotrexate-etanercept combination over the...
From the Journals
New diagnostic tool identifies severe ADAMTS13 deficiency
A new diagnostic tool – the PLASMIC score – predicts severe ADAMTS13 deficiency, effectively distinguishing thrombotic thrombocytopenic purpura...
Conference Coverage
How to get the most out of methotrexate for psoriasis
WAILEA, HAWAII – Methotrexate is the most cost-effective way to manage extensive psoriasis.
Conference Coverage
Lupus low disease activity definition gains momentum
MELBOURNE – Evidence for the validity of using Lupus Low Disease Activity State (LLDAS) as a measurement tool both in clinical trials and clinical...
Feature
Medicaid reform: Work-based waivers may not fly
High mandatory premiums, cost sharing, lifetime limits, drug testing move Medicaid from a health care program to a work program, advocates argue...
Feature
CMS market stabilization efforts useless without subsidies
President Trump has threatened to withhold insurer subsidies in an effort to bring Congressional Democrats to the health care negotiation table....
From the Journals
Study shows no adverse events with long-term denosumab in postmenopausal women
Denosumab, taken long term, is not linked with any adverse events, an analysis of the participants in the FREEDOM trial showed.
From the Journals
CCP status doesn’t influence tocilizumab’s effectiveness in RA
Cyclic citrullinated peptide seronegativity did not improve tocilizumab response in real-world patients.
Conference Coverage
MicroRNAs linked to treatment response in lupus nephritis
MELBOURNE – Expression of six microRNAs in kidney biopsy samples helped to predict response to cyclophosphamide.
From the Journals
Obesity in women with RA greatly influences CRP levels
A study’s findings suggest interpreting C-reactive protein levels cautiously in obese women with rheumatoid arthritis.